Patent details

EP1991267 Title: METHODS OF TREATING INFLAMMATORY AND AUTOIMMUNE DISEASES WITH NATALIZUMAB

Basic Information

Publication number:
EP1991267
PCT Application Number:
US2007005265
Type:
European Patent Granted for LU
Legal Status:
Revoked
Application number:
EP077519932
PCT Publication Number:
WO2007103112
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
METHODS OF TREATING INFLAMMATORY AND AUTOIMMUNE DISEASES WITH NATALIZUMAB
French Title of Invention:
PROCÉDÉS DE TRAITEMENT DE MALADIES INFLAMMATOIRES ET AUTO-IMMUNES AVEC DU NATALIZUMAB
German Title of Invention:
VERFAHREN ZUR BEHANDLUNG VON ENTZÜNDUNGS- UND AUTOIMMUNERKRANKUNGEN MIT NATALIZUMAB
SPC Number:

Dates

Filing date:
02/03/2007
Grant date:
20/12/2017
EP Publication Date:
19/11/2008
PCT Publication Date:
13/09/2007
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
20/12/2017
EP B1 Publication Date:
20/12/2017
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
02/03/2018
Expiration date:
02/03/2027
Renunciation date:
Revocation date:
12/10/2021
Annulment date:

Owner

From:
13/12/2017
 
 

Name:
BIOGEN MA INC.
Address:
225 Binney Street, Cambridge, MA 02142, United States (US)

Inventor

Name:
YEDNOCK, Theodore, A.
Address:
United States (US)

Priority

Priority Number:
779190 P
Priority Date:
03/03/2006
Priority Country:
United States (US)

Classification

IPC classification:
A61K 39/00; A61K 39/395; C07K 16/28; G01N 33/68;

Publication

European Patent Bulletin

1

Issue number:
201751
Publication date:
20/12/2017
Description:
Grant (B1)

2

Issue number:
201803
Publication date:
17/01/2018
Description:
Application number/publication number of the divisional application (Art. 76) changed

3

Issue number:
201844
Publication date:
31/10/2018
Description:
Opposition procedure started

4

Issue number:
202146
Publication date:
17/11/2021
Description:
Revocation of the European patent

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
31/07/2018 Outgoing Correspondence 1